StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Sona gets a kick in the teeth. Down 68%.

<< Previous

Bullboard Posts

Next >>

Comment by molotov420on Jun 11, 2021 12:27pm

153 Views

Post# 33372713

RE:RE:Sona gets a kick in the teeth. Down 68%.

They reported almost 500K for 2020, however the cancer revs seem to have tried up again in Q1. I asked both IR and Tripp about the increase in 2020 and go nothing...SAD. Starting to think it was a typo meant to read $500 not 500K.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland